Oryzon Genomics SA (ORY) Stock Price & News

ORY:BME

Oryzon Genomics SA

€2.35

-8.93%

(-0.23) 1D

Nov 13, 5:36:00 PM GMT+1 · EUR

All symbols

	Symbol	Price	Change	% Change

Last report

Nov 17, 2026

Fiscal period

Q3 2026

-€0.02 / -€0.06

+71.06%beat

Revenue / Est. (EUR)

- / 0.00

Fiscal Q3 2026 earnings call

Waiting for the earnings call

At a glance

Insights from the latest news and reports

Previous reportsAll values in EUR

Loading Previous Earnings...

All values in EUR	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	10.93M	-	8.69M
Cost of goods sold	-	282.49K	-	210.97K
Cost of revenue	-	282.49K	-	210.97K
Research and development expenses	-	-8.20M	-	-4.53M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	-	480.49K	-	793.29K
Operating expense	-	4.85M	-	5.81M
Total operating expenses	-	5.14M	-	6.02M
Operating income	-	5.80M	-	2.67M
Other non operating income	-	-8.22M	-	-4.09M
EBT including unusual items	-	-4.34M	-	-1.97M
EBT excluding unusual items	-	-4.34M	-	-2.00M
Income tax expense	-	-2.99M	-	-1.83M
Effective tax rate	-	68.94%	-	93.12%
Other operating expenses	-	12.44M	-	9.48M
Net income	-	-1.35M	-	-135.49K
Net profit margin	-	-12.33%	-	-1.56%
Earnings per share	0.01	-0.02	-0.02	-
Interest and investment income	-	-	-	-
Interest expense	-	-1.98M	-	-619.42K
Net interest expenses	-	-1.98M	-	-619.42K
Depreciation and amortization charges	-	133.91K	-	62.62K
EBITDA	-	5.83M	-	2.70M
Gain or loss from assets sale	-	-	-	-

Finance